Chennai, October 2018: Gleneagles Global Health City, the largest facility of Gleneagles Global Hospitals, a Parkway Pantai enterprise, hosted the first International Conference on Lung Transplant and Advanced Management of Interstitial Lung Diseases, titled, ‘ILDCON 2018’ in Chennai today. The ILDCON conference witnessed a wide spread and enthusiastic participation medical experts from India and across the world that included about 350 specialist pulmonologists, intensivists and cardio-thoracic surgeons and about 100 international and national faculty of highest repute. Padma Bhushan Shri Kamal Haasan, Actor, Founder and President of Makkal Needhi Maiam, inaugurated the event. Dr J. Radhakrishnan, IAS, Principal Secretary – Health and Family Welfare Department, Govt. of Tamil Nadu, addressed the gathering stressing on the importance of organ donation and transplantation.
ILDCON was envisaged by Dr Sandeep Attawar, Chairman and Program Director, Institute of Heart & Lung Transplantation, Gleneagles Global Hospitals, and Dr Apar Jindal, Transplant Pulmonologist, Gleneagles Global Health City as a means to deliver high quality teaching in the field of end stage lung disease and transplantation. The conference is dazzled with participation by national & international experts in the field of advanced management of end stage lung disease, pulmonary critical care, thoracic surgery and lung transplantation. The scientific programme comprises of lectures, interactive panel discussions, and case discussions.
World renowned pulmonary and cardio-thoracic transplant experts from USA such as Dr Steves Ring, Dr Fernando Torres, Dr Harish Seethamraju, Dr Ganesh Raghu, Dr Srinivas Bollineni, Dr NamitaSood and Dr David Naidich contributed to make the event a huge success.
The Heart and Lung Transplant Program at Gleneagles Global Health City was established in 2011, when the first successful single lung transplant in India was done. The current heart & lung transplant team has the largest experience in the field with 100 transplants including 50 hearts and 50 lungs to their credit, in the last 18 months. With a post transplantation success rate at par with international standards, the Heart & Lung Transplant Program has given a very robust and viable treatment option to patients suffering from End Stage Lung Disease from India and abroad.
Few of the patients who had undergone successful lung transplantation at Institute of Heart & Lung Transplant, Gleneagles Global Health City, were present at the event to share the story of their life journey from being diagnosed with an incurable lung disease, progressively adding to their misery and making daily living and breathing a burden to the disease free healthy normal life post lung transplantation.
Dr Sandeep Attawar, Chairman and Program Director, Institute of Heart & Lung Transplant, Gleneagles Global Hospitals, said “The burden of end stage lung disease worldwide is staggering. The lack of definitive therapeutic options has been for long the bane of clinicians and patients alike. Our consistent, reproducible and successful outcomes following lung transplantation at Gleneagles Global Hospitals will be the catalyst, that will bring about the new, desired and confident approach to this crippling disease”
Dr Apar Jindal, Transplant pulmonologists, Gleneagles Global Health City, Said “Lung Transplantation has come to stay as a visible long term therapeutic option not merely by scientific advancements or trained clinical teams. All of this is made possible by the unparalled generosity of donor families, the tireless efforts of NGO’s, grief counselors, donor coordinators and TRANSTAN, ably supported by the health care administration of the state Government”.
Dr VijilRahulan, Head Transplant Pulmonology, Gleneagles Global Health City, said “Outcome reporting after organ transplant is standard practice worldwide. Outcome reporting to a scientific body allows for quality assessment, performance review, improvement and a tireless quest for self-introspection and greater care. We are proud to be reporting our outcomes to the ISHLT consistently, elaborately and accurately. We believe this has accelerated our evolution as the premier service in Heart and Lung Transplantation across India”.
Dr Ajay Bakshi, Chief Executive Officer, Indian Operations Division, Parkway Pantai Limited said “It is matter of great pride at Parkway to support the world class Lung Transplant program at ILDCON under the stewardship of Dr. SandeepAttawar .It is through this high quality academic institute that we would like to not just raise awareness but support endeavors to tackle advanced lung disease”.